ADAR1 Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $500K | Buy |
35,716
+21,843
| +157% | +$306K | 0.08% | 114 |
|
|
2025
Q1 | $189K | Sell |
13,873
-30,953
| -69% | -$421K | 0.04% | 144 |
|
|
2024
Q4 | $914K | Sell |
44,826
-57,000
| -56% | -$1.16M | 0.18% | 82 |
|
|
2024
Q3 | $2.97M | Buy |
101,826
+63,826
| +168% | +$1.86M | 0.48% | 37 |
|
|
2024
Q2 | $882K | Buy |
38,000
+36,000
| +1,800% | +$836K | 0.17% | 66 |
|
|
2024
Q1 | $41K | Buy |
+2,000
| New | +$41K | 0.01% | 173 |
|